Visualizar Tese - Instituto de Biociências - Unesp
Visualizar Tese - Instituto de Biociências - Unesp Visualizar Tese - Instituto de Biociências - Unesp
Cirilo, PDRREFERÊNCIAS217Jacobson EM, Hugo ER, Borcherding DC et al. Prolactin in breast and prostate cancer: molecular andgenetic perspectives. Discov Med, 11, 315-324, 2011.Jacoby VL, Fujimoto VY, Giudice LC et al. Racial and ethnic disparities in benign gynecologicconditions and associated surgeries. Am J Obstet Gynecol, 202, 514-521, 2010.Jashnani KD, Agrawal VR, Naik LP. Metastasis of breast lobular carcinoma in a cervical leiomyoma.Indian J Pathol Microbiol, 50, 378-379, 2007.Jensen KB, Dredge BK, Stefani G et al. Nova-1 regulates neuron-specific alternative splicing and isessential for neuronal viability. Neuron, 25, 359–371, 2000.Jeong YJ, Noh EM, Lee YR et al. 17beta-estradiol induces up-regulation of PTEN and PPARgamma inleiomyoma cells, but not in normal cells. Int J Oncol, 36, 921-927, 2010.Jiang Y, Suo G and Sadarangani A. Expression profiling of protein tyrosine kinases and their ligandactivators in leiomyoma uteri. Syst Biol Reprod Med, 56, 318–326, 2010.Jin M, Tanaka S, Sekino Y et al. A novel, brain-specific mouse drebrin: cDNA cloning, chromosomalmapping, genomic structure, expression, and functional characterization. Genomics, 79, 686-692, 2002.Jones MR, Italiano L, Wilson SG et al. Polymorphism in HSD17B6 is associated with key features ofpolycystic ovary syndrome. Fertil Steril, 86, 1438-1446, 2006.Jönsson G, Staaf J, Vallon-Christersson J et al. Genomic subtypes of breast cancer identified by arraycomparativegenomic hybridization display distinct molecular and clinical characteristics.Breast Cancer Res, 12, 2010.Kallioniemi A, Kallioniemi OP, Sudar D et al. Comparative genomic hybridization for molecularcytogenetics analysis of solid tumors. Science, 258, 818-821, 1992.Kanamori T, Takakura K, Mandai M et al. PEP-19 overexpression in human uterine leiomyoma. MolHum Reprod, 9, 709-717, 2003.Kandalaft PL and Esteban JM. Bilateral massive ovarian leiomyomata in a young woman: a casereport with review of the literature. Mod Pathol, 5, 586-589, 1992.Katoh M. Genetic alterations of FGF receptors: an emerging field in clinical cancer diagnostics andtherapeutics. Expert Rev Anticancer Ther, 10, 1375-1379, 2010.Käufl SD, Makovitzky J, Kuhn C et al. Inhibin/activin-betaC subunit in human endometrialadenocarcinomas and HEC-1a adenocarcinoma cell line. In Vivo, 24, 695-698, 2010.Kawaguchi K, Fujii S, Konishi I et al Ultrastructural study of cultured smooth muscle cells fromuterine leiomyoma and myometrium under the influence of sex steroids. Gynecol Oncol, 21,32-41, 1985.Kayisli UA, Berkkanoglu M, Kizilay G et al. Expression of proliferative and preapoptotic molecules inhuman myometrium and leiomyoma throughout the menstrual cycle. Reprod Sci, 14, 678-686, 2007.
Cirilo, PDRREFERÊNCIAS218Kazmierczak B, Bol S, Wanschura S et al. Pac clone containing the HMGI(Y) gene spans thebreakpoint of a 6p21 translocation in a uterine leiomyoma cell line. Genes ChromosomesCancer, 17, 191-193, 1996.Kazmierczak B, Wanschura S, Rosigkeit J et al. Molecular characterization of 12q14–15rearrangements in three pulmonary chondroid hamartomas. Cancer Res, 55, 2497–2499,1995.Ke L, Che YN, Cao YX et al. Polymorphisms of the HSD17B6 and HSD17B5 genes in Chinese womenwith polycystic ovary syndrome. J Womens Health, 19, 2227-2232, 2010.Khorram O, Garthwaite M, Golos T. Uterine and ovarian aryl hydrocarbon receptor (AHR) and arylhydrocarbon receptor nuclear translocator (ARNT) mRNA expression in benign andmalignant gynaecological conditions. Mol Hum Reprod, 8, 75-80, 2002.Kimmich T, Brüning A, Käufl SD et al. Inhibin/activin-betaC and -betaE subunits in the Ishikawahuman endometrial adenocarcinoma cell line. Arch Gynecol Obstet, 282, 185-191, 2010.Kondo NI, Yoshida S, Kajiyama H et al. Metastasis of breast cancer to a uterine leiomyoma. BreastCancer, 16, 157-161, 2009.Kools PF and Van de Ven WJ. Amplification of a rearranged form of the high mobility group proteingene hmgic in osteosarcoma cells. Cancer Genet Cytogenet, 91, 1–7, 1996.Kroeger H, Jelinek J, Estécio MR. Aberrant CpG island methylation in acute myeloid leukemia isaccentuated at relapse. Blood, 112, 1366-1373, 2008.Kuivaniemi H, Tromp G, Prockop DJ. Mutations in collagen genes: causes of rare and some commondiseases in humans. FASEB J, 5, 2052-2060, 1991.Laganà A, Russo F, Sismeiro C et al. Variability in the incidence of miRNAs and genes in fragile sitesand the role of repeats and CpG islands in the distribution of genetic material. PLoS One, 17,e11166, 2010.Lara PC, Lloret M, Clavo B et al. Severe hypoxia induces chemo-resistance in clinical cervical tumorsthrough MVP over-expression. Radiat Oncol, 6, 1-14, 2009.Laser L, Lee P and Wei J. Cellular senescence in usual type uterine leiomyoma. Fertil Steril, 93,2020-2026, 2010.Laurila E, Savinainen K, Kuuselo R et al. Characterization of the 7q21-q22 amplicon identifiesARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion inpancreatic cancer. Genes Chromosomes Cancer, 48, 330-339, 2009.Lavecchia A, Di Giovanni C, Novellino E. Inhibitors of Cdc25 phosphatases as anticancer agents: apatent review. Expert Opin Ther Pat, 20, 405-425, 2010.Lea IA, Jackson MA, Li X et al. Genetic pathways and mutation profiles of human cancers: site- andexposure-specific patterns. Carcinogenesis, 28, 1851-1858, 2007.
- Page 189 and 190: Cirilo, PDRDISCUSSÃO166Desde 1991,
- Page 191 and 192: Cirilo, PDRDISCUSSÃO168núcleo das
- Page 193 and 194: Cirilo, PDRDISCUSSÃO170sobre LHFPL
- Page 195 and 196: Cirilo, PDRDISCUSSÃO172outras cate
- Page 197 and 198: Cirilo, PDRDISCUSSÃO174Entre as ou
- Page 199 and 200: Cirilo, PDRDISCUSSÃO176regiões de
- Page 201 and 202: Cirilo, PDRDISCUSSÃO178da RNA Pol
- Page 203 and 204: Cirilo, PDRDISCUSSÃO180proliferati
- Page 205 and 206: Cirilo, PDRDISCUSSÃO182Entre os 20
- Page 207 and 208: Cirilo, PDRDISCUSSÃO184propôs um
- Page 209 and 210: Cirilo, PDRDISCUSSÃO186analisados
- Page 211 and 212: Cirilo, PDRDISCUSSÃO188observados
- Page 213 and 214: Cirilo, PDRDISCUSSÃO190moduladores
- Page 215 and 216: Cirilo, PDRDISCUSSÃO192genômica/d
- Page 217 and 218: Cirilo, PDRDISCUSSÃO194identificar
- Page 219 and 220: Cirilo, PDRDISCUSSÃO196e também d
- Page 221 and 222: Cirilo, PDRDISCUSSÃO198O gene COL3
- Page 223 and 224: Cirilo, PDRDISCUSSÃO200resistênci
- Page 225 and 226: Cirilo, PDRDISCUSSÃO202bioquímica
- Page 227 and 228: Cirilo, PDRDISCUSSÃO204carcinoma c
- Page 229 and 230: Cirilo, PDRCONCLUSÕES DISCUSSÃO20
- Page 231 and 232: Cirilo, PDRREFERÊNCIAS2087. Refer
- Page 233 and 234: Cirilo, PDRREFERÊNCIAS210Brazelle
- Page 235 and 236: Cirilo, PDRREFERÊNCIAS212Churikov
- Page 237 and 238: Cirilo, PDRREFERÊNCIAS214Gannon BR
- Page 239: Cirilo, PDRREFERÊNCIAS216Holthause
- Page 243 and 244: Cirilo, PDRREFERÊNCIAS220Lloret M,
- Page 245 and 246: Cirilo, PDRREFERÊNCIAS222Mitra R,
- Page 247 and 248: Cirilo, PDRREFERÊNCIAS224Ozisik YY
- Page 249 and 250: Cirilo, PDRREFERÊNCIAS226Redon R,
- Page 251 and 252: Cirilo, PDRREFERÊNCIAS228Solyom S,
- Page 253 and 254: Cirilo, PDRREFERÊNCIAS230Ueki K, R
- Page 255 and 256: Cirilo, PDRREFERÊNCIAS232and poly(
- Page 257 and 258: Skubitz KM e Skubitz APJ Lab Clin M
- Page 259 and 260: Dimitrova IK et al. Fertil Steril,9
- Page 261 and 262: 317T_B317T_C13 614T 44 LU prolifera
- Page 263 and 264: 46 867T 46 LUM outros B 14 33,5 17
- Page 265 and 266: 1015T 6q13-q14.1 75,806,978-76,314,
- Page 267 and 268: MRPS31, SLC25A15, SUGT1L1 320d-1630
- Page 269 and 270: 8q22.3-q23.1 105,831,966 107,742,33
- Page 271 and 272: Anexo 5. Genes identificados na an
- Page 273 and 274: + + CCDC8 0 51 37 14+ - CALM3 51 0
- Page 275 and 276: ABSTRACTBackground: Uterine leiomyo
- Page 277 and 278: Thus, these findings prompt us to i
- Page 279 and 280: Technologies, Santa Clara, CA). Sta
- Page 281 and 282: mapped at 1p36.13, 1q41, 2q32.1, 2q
- Page 283 and 284: genetic disorder showed the higher
- Page 285 and 286: The modulators were mainly associat
- Page 287 and 288: egulation of cell cycle. Chegini an
- Page 289 and 290: REFERENCES[1] Baird DD, Dunson DB (
Cirilo, PDRREFERÊNCIAS218Kazmierczak B, Bol S, Wanschura S et al. Pac clone containing the HMGI(Y) gene spans thebreakpoint of a 6p21 translocation in a uterine leiomyoma cell line. Genes ChromosomesCancer, 17, 191-193, 1996.Kazmierczak B, Wanschura S, Rosigkeit J et al. Molecular characterization of 12q14–15rearrangements in three pulmonary chondroid hamartomas. Cancer Res, 55, 2497–2499,1995.Ke L, Che YN, Cao YX et al. Polymorphisms of the HSD17B6 and HSD17B5 genes in Chinese womenwith polycystic ovary syndrome. J Womens Health, 19, 2227-2232, 2010.Khorram O, Garthwaite M, Golos T. Uterine and ovarian aryl hydrocarbon receptor (AHR) and arylhydrocarbon receptor nuclear translocator (ARNT) mRNA expression in benign andmalignant gynaecological conditions. Mol Hum Reprod, 8, 75-80, 2002.Kimmich T, Brüning A, Käufl SD et al. Inhibin/activin-betaC and -betaE subunits in the Ishikawahuman endometrial a<strong>de</strong>nocarcinoma cell line. Arch Gynecol Obstet, 282, 185-191, 2010.Kondo NI, Yoshida S, Kajiyama H et al. Metastasis of breast cancer to a uterine leiomyoma. BreastCancer, 16, 157-161, 2009.Kools PF and Van <strong>de</strong> Ven WJ. Amplification of a rearranged form of the high mobility group proteingene hmgic in osteosarcoma cells. Cancer Genet Cytogenet, 91, 1–7, 1996.Kroeger H, Jelinek J, Estécio MR. Aberrant CpG island methylation in acute myeloid leukemia isaccentuated at relapse. Blood, 112, 1366-1373, 2008.Kuivaniemi H, Tromp G, Prockop DJ. Mutations in collagen genes: causes of rare and some commondiseases in humans. FASEB J, 5, 2052-2060, 1991.Laganà A, Russo F, Sismeiro C et al. Variability in the inci<strong>de</strong>nce of miRNAs and genes in fragile sitesand the role of repeats and CpG islands in the distribution of genetic material. PLoS One, 17,e11166, 2010.Lara PC, Lloret M, Clavo B et al. Severe hypoxia induces chemo-resistance in clinical cervical tumorsthrough MVP over-expression. Radiat Oncol, 6, 1-14, 2009.Laser L, Lee P and Wei J. Cellular senescence in usual type uterine leiomyoma. Fertil Steril, 93,2020-2026, 2010.Laurila E, Savinainen K, Kuuselo R et al. Characterization of the 7q21-q22 amplicon i<strong>de</strong>ntifiesARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion inpancreatic cancer. Genes Chromosomes Cancer, 48, 330-339, 2009.Lavecchia A, Di Giovanni C, Novellino E. Inhibitors of Cdc25 phosphatases as anticancer agents: apatent review. Expert Opin Ther Pat, 20, 405-425, 2010.Lea IA, Jackson MA, Li X et al. Genetic pathways and mutation profiles of human cancers: site- an<strong>de</strong>xposure-specific patterns. Carcinogenesis, 28, 1851-1858, 2007.